Evidence map›Paper›PMID 34441034›Full record

ReviewMedicina (Kaunas, Lithuania)2021

Erythema Multiforme and COVID-19: What Do We Know?

Luigi Bennardo, Steven Paul Nisticò, Stefano Dastoli, Eugenio Provenzano, Maddalena Napolitano, Martina Silvestri, Maria Passante, Cataldo Patruno

Abstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Erythema multiforme in children.Canadian family physician Medecin de famille canadien · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech).Proceedings (Baylor University. Medical Center) · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luigi BennardoDepartment of Health Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0002-0434-1027
Steven Paul NisticòDepartment of Health Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.
Stefano DastoliDepartment of Health Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.
Eugenio ProvenzanoUnit of Dermatology, Mariano Santo Hospital, 87100 Cosenza, Italy.
Maddalena NapolitanoDepartment of Health Sciences V. Tiberio, University of Molise, 86100 Campobasso, Italy.ORCID 0000-0003-3309-8190
Martina SilvestriDepartment of Health Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0002-1828-780X
Maria PassanteDepartment of Health Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.
Cataldo PatrunoDepartment of Health Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0001-8661-2822

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Erythema MultiformeAdultHumansHydroxychloroquineSARS-CoV-2HydroxychloroquineCOVID-19erythema multiformehydroxychloroquineSARS-CoV-2

Identifiers

PMID34441034
PMCPMC8401222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.